Coeptis Therapeutics Holdings Balance Sheet Health
Financial Health criteria checks 5/6
Coeptis Therapeutics Holdings has a total shareholder equity of $5.0M and total debt of $1.7M, which brings its debt-to-equity ratio to 34.2%. Its total assets and total liabilities are $9.0M and $4.0M respectively.
Key information
34.2%
Debt to equity ratio
US$1.70m
Debt
| Interest coverage ratio | n/a |
| Cash | US$1.14m |
| Equity | US$4.98m |
| Total liabilities | US$3.97m |
| Total assets | US$8.96m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: COEP's short term assets ($1.4M) do not cover its short term liabilities ($3.4M).
Long Term Liabilities: COEP's short term assets ($1.4M) exceed its long term liabilities ($533.3K).
Debt to Equity History and Analysis
Debt Level: COEP's net debt to equity ratio (11.4%) is considered satisfactory.
Reducing Debt: COEP's debt to equity ratio has reduced from 794.8% to 34.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: COEP has sufficient cash runway for 2 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: COEP is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.